CVD Completes Purchase of 180,000 Sq. Ft. Facility

December 6, 2017

CENTRAL ISLIP, N.Y.–(BUSINESS WIRE)–CVD Equipment Corporation (NASDAQ: CVV),
a leading provider of chemical vapor deposition systems and materials
announced today that it has completed the purchase of the Company’s
planned additional facility, located at 555 North Research Place,
Central Islip, NY. This new facility will be the primary manufacturing
center for the Company’s wholly owned subsidiary, CVD Materials
Corporation.

Leonard A. Rosenbaum, President and Chief Executive Officer stated,
“With the completion of this purchase we now have the manufacturing
space to accelerate our capabilities of providing materials, coatings,
and surface treatments to meet our customers’ needs. We look forward to
the expansion of our carbon composites and electronic material,
Tantaline®, and newly acquired MesoScribe™, product lines. We also
anticipate future growth, both organically and by possible future
acquisitions. With the purchase behind us, we are now focusing on
bringing the new facility on-line and for additional growth
opportunities enabled by this additional 180,000 square foot facility.”

About CVD Equipment Corporation

CVD Equipment Corporation (NASDAQ: CVV)
designs, develops, and manufactures a broad range of chemical vapor
deposition, gas control, and other state-of-the-art equipment and
process solutions used to develop and manufacture materials and coatings
for research and industrial applications. This equipment is used by its
customers to research, design, and manufacture these materials or
coatings for aerospace engine components, medical implants,
semiconductors, solar cells, smart glass, carbon nanotubes, nanowires,
LEDs, MEMS, and other applications. Through its application laboratory,
the Company provides process development support and process startup
assistance with the focus on enabling tomorrow’s technologies™. Its
wholly owned subsidiary CVD Materials Corporation provides advanced
materials and metal surface treatments and coatings to serve demanding
applications in the electronic, biomedical, petroleum, pharmaceutical,
and many other industrial markets.

The Private Securities Litigation Reform Act of 1995 provides a “safe
harbor” for forward-looking statements. Certain information included in
this press release (as well as information included in oral statements
or other written statements made or to be made by CVD Equipment
Corporation) contains statements that are forward-looking. All
statements other than statements of historical fact are hereby
identified as “forward-looking statements, “as such term is defined in
Section 27A of the Securities Exchange Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Such
forward looking information involves a number of known and unknown risks
and uncertainties that could cause actual results to differ materially
from those discussed or anticipated by management. Potential risks and
uncertainties include, among other factors, conditions, success of CVD
Equipment Corporation’s growth and sales strategies, the possibility of
customer changes in delivery schedules, cancellation of orders,
potential delays in product shipments, delays in obtaining inventory
parts from suppliers and failure to satisfy customer acceptance
requirements.